Provide Greater Access to Affordable Medications for Uninsured and Underinsured Families
SUNRx automated solutions help hospitals create, manage, and expand 340B contract pharmacy relationships.
SUNRx is a full spectrum solutions company offering covered entities a 340B contract pharmacy solution that benefits your hospital and your patients for no additional cost.
SUNRx’s automated solutions can help Pennsylvania hospitals:
- Provide greater access to affordable medications for uninsured and underinsured families
- Expand your hospital's reach into the community and maximize prescription savings
With no start-up cost to member hospitals and health systems, the SUNRx team can implement a successful program that expands patient access to medications.
Eligible hospitals wanting to expand their 340B program now have the opportunity to contract with multiple community pharmacies to ensure a robust pharmacy network for their patients.
Eligible Facilities: Nonprofit hospitals that provide health care services to low-income, uninsured individuals, and maintain a DSH percentage exceeding 11.75 percent are eligible.
The Affordable Care Act of 2010 expanded 340B eligibility to include critical access hospitals, rural referral centers, and sole community hospitals, in addition to the previously covered disproportionate share hospitals.
SUNRx Technology: SUNRx has extensive experience implementing and maintaining contract pharmacy services. The SUNRx virtual inventory technology and 340B management products capture patients’ prescriptions filled at contracted pharmacies.
SUNRx verifies patient and prescriber eligibility and assures 340B compliance. Its industry-leading auditing, tracking, and financial management features provide hospital leaders with up-to-the-minute information about their facility's 340B program savings.
For a free analysis of how the SUNRx 340B contract pharmacy network solution can benefit your hospital and your patients, please contact Shawn Ullom at (267) 290-8766. Download the brochure or contact HAP’s Daneen Schroder for additional information.